Epigenetic regulation of RhoB loss of expression in lung cancer
2007

How RhoB Expression is Regulated in Lung Cancer

publication Evidence: moderate

Author Information

Author(s): Mazières Julien, Tovar Daniel, He Biao, Nieto-Acosta Jacobo, Marty-Detraves Claire, Clanet Carine, Pradines Anne, Jablons David, Favre Gilles

Primary Institution: INSERM U563 – Département Innovation Thérapeutique et Oncologie Moléculaire, Toulouse, France

Hypothesis

RhoB loss of expression in lung cancer is due to epigenetic regulation rather than genetic mutations.

Conclusion

RhoB expression is mainly regulated by histone deacetylation rather than promoter hypermethylation.

Supporting Evidence

  • RhoB is down-regulated in most lung cancer cell lines and tumor tissues compared to normal tissues.
  • Histone deacetylase inhibitors significantly induce RhoB re-expression in lung cancer cell lines.
  • Promoter hypermethylation was not found to be the main mechanism of RhoB inactivation.

Takeaway

RhoB is a gene that helps control cancer growth, and scientists found that changing how it is turned on or off can help fight lung cancer.

Methodology

The study analyzed RhoB expression using HDAC inhibitors and methyltransferase inhibitors, along with bisulfite treatment and methylation specific PCR.

Limitations

The study did not explore all potential genetic alterations that could affect RhoB expression.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-7-220

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication